A new therapeutic concept for long-lasting iatrogenic priapism: a case report.
In a therapeutic attempt on an 18-year-old patient with iatrogenic priapism lasting for more than 2 weeks after internal urethrotomy, intracavernous lysis was commenced with 80,000 IU streptokinase per hour. Following a dosage of 300,000 IU streptokinase the lysis was stopped because of severe bleeding from the urethrotomy scar. At 4 weeks after the patient was discharged from the hospital he reported normal erections and intercourse, while single potential analysis of cavernous electrical activity and ultrasound returned to normal. Provided there are no contraindications, intracavernous lysis seems to be an effective treatment for long-lasting priapism induced by intracavernous thrombosis.
Freymann
H
H
Department of Urology, Medical School Hannover, Germany.
Djamilian
M
M
Thon
W F
WF
Stief
C G
CG
Jonas
U
U
D000293:Adolescent; D006801:Humans; D007431:Intraoperative Complications / Q000188:drug therapy*; D008297:Male; D011317:Priapism / Q000188:drug therapy*; D013300:Streptokinase / Q000627:therapeutic use*; D013997:Time Factors; D014525:Urethral Stricture / Q000601:surgery
D013300:Streptokinase